Product Information
LIDOCAINE HCL 2% JEL UROJET AC is a generic product labeled by International Medication Systems, Limited, priced at $1.1666 per ML under NDC 76329301105. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Lidocaine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
International Medication Systems, LimitedNDC
76329301105
Classification
Generic
Dosage Form
JELLY
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA086283FDA Approved
Before 1982
TE Code
AT
On Market Since
8/7/1979
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% JEL UROJET AC has been published 142 times since Jan 17, 2024, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1666 per ML |
|---|---|
| All-time high | $1.1776 (Feb 11, 2026) |
| All-time low | $0.9884 (Jul 17, 2024) |
| 52-week high | $1.1776 |
| 52-week low | $1.1658 |
| Median price | $1.1671 |
| Average price | $1.1077 |
| Largest weekly change | +5.7% (Jan 22, 2025) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
International Medication Systems, Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% JEL UROJET AC?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% JEL UROJET AC, manufactured by International Medication Systems, Limited, is $1.1666 per ML (NDC 76329301105), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 2% JEL UROJET AC changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% JEL UROJET AC has risen 15.6%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% JEL UROJET AC?
Since Jan 17, 2024, the NADAC for LIDOCAINE HCL 2% JEL UROJET AC has ranged from a low of $0.9884 (Jul 17, 2024) to a high of $1.1776 (Feb 11, 2026), with a median of $1.1671 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% JEL UROJET AC?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 2% JELLY URO-JET, is $0.7040 per ML — about 40% below LIDOCAINE HCL 2% JEL UROJET AC.
Who manufactures LIDOCAINE HCL 2% JEL UROJET AC?
LIDOCAINE HCL 2% JEL UROJET AC (NDC 76329301105) is labeled by International Medication Systems, Limited, and CMS classifies it as a generic product.